Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma Cells. [electronic resource]
Producer: 20171024Description: 345-355 p. digitalISSN:- 1868-8500
- Adrenal Cortex Neoplasms -- drug therapy
- Adrenocortical Carcinoma -- drug therapy
- Antineoplastic Agents, Hormonal -- pharmacology
- Bortezomib -- pharmacology
- Cell Line, Tumor
- Cell Survival -- drug effects
- Drug Synergism
- Drug Therapy, Combination
- Endoplasmic Reticulum Stress -- drug effects
- Endoribonucleases -- genetics
- Eukaryotic Initiation Factor-2 -- metabolism
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Leupeptins -- pharmacology
- Mitotane -- pharmacology
- Oligopeptides -- pharmacology
- Phosphorylation
- Proteasome Inhibitors -- pharmacology
- Protein Serine-Threonine Kinases -- genetics
- X-Box Binding Protein 1 -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.